2008年我院口服调血脂药使用调查分析

Analysis on the use of oral Lipidemic-modulating drugs in our hospital in 2008

目的:对医院调血脂药物的使用情况进行分析评估,为临床合理用药提供参考依据。方法:采用药物限定日剂量(DDD值)分析方法,统计我院2008年口服调血脂药的用药频度(DDDs)、销售金额、每日药费(DDC)等数据。结果:阿托伐他汀(立普妥)的销售金额最高。DDDs排序位于前3位的分别是辛伐他汀、辛伐他汀(舒降之)、普伐他汀(普拉固)。结论:医院调血脂药物中他汀类调血脂药物占主要地位。

Objective： To evaluate the use of oral Lipidemic-modulating drugs in our hospital in order to provide an reference for rational use of drugs in clinic. Methods： DDDs, sales volume, and daily expenses of drugs in our hospital in 2008 were analyzed with the method of DDD analysis. Results： The maximum amount of sales was atorvastatin （Lipitor）. DDDs sort of the former three were simvastatin, simvastatin （Zocor）, pravastatin （pravastatin）.Conclusion： In our hospital oral Lipidemic-modulating drugs, Lipidemic-modulating drugs occupy the main status.